Chicago Partners Investment Group LLC lifted its holdings in Johnson & Johnson (NYSE:JNJ) by 9.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,714 shares of the company’s stock after buying an additional 1,144 shares during the period. Chicago Partners Investment Group LLC’s holdings in Johnson & Johnson were worth $1,653,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of the company. Harding Loevner LP purchased a new stake in shares of Johnson & Johnson during the second quarter worth $106,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its holdings in shares of Johnson & Johnson by 29.9% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock worth $115,000 after acquiring an additional 200 shares in the last quarter. IHT Wealth Management LLC raised its holdings in shares of Johnson & Johnson by 46.4% during the second quarter. IHT Wealth Management LLC now owns 10,942 shares of the company’s stock worth $122,000 after acquiring an additional 3,467 shares in the last quarter. Mountain Capital Investment Advisors Inc purchased a new stake in shares of Johnson & Johnson during the second quarter worth $124,000. Finally, Shine Investment Advisory Services Inc. purchased a new stake in shares of Johnson & Johnson during the second quarter worth $177,000. 67.35% of the stock is owned by institutional investors and hedge funds.
Johnson & Johnson (JNJ) opened at $133.68 on Friday. Johnson & Johnson has a 1-year low of $120.95 and a 1-year high of $148.32. The company has a current ratio of 1.41, a quick ratio of 1.12 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $357,250.00, a PE ratio of 24.62, a price-to-earnings-growth ratio of 2.10 and a beta of 0.77.
Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings data on Tuesday, January 23rd. The company reported $1.74 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.02. The business had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.08 billion. Johnson & Johnson had a return on equity of 29.00% and a net margin of 1.70%. The firm’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.58 earnings per share. equities research analysts anticipate that Johnson & Johnson will post 8.11 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 13th. Stockholders of record on Tuesday, February 27th were paid a $0.84 dividend. The ex-dividend date was Monday, February 26th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.51%. Johnson & Johnson’s payout ratio is presently 61.88%.
Several analysts recently issued reports on JNJ shares. BTIG Research reiterated a “sell” rating and set a $110.00 price objective on shares of Johnson & Johnson in a report on Wednesday, January 24th. Vetr lowered Johnson & Johnson from a “buy” rating to a “hold” rating and set a $147.40 price objective for the company. in a report on Monday, January 8th. Credit Suisse Group set a $154.00 price objective on Johnson & Johnson and gave the stock a “hold” rating in a report on Monday, January 22nd. BMO Capital Markets increased their price objective on Johnson & Johnson to $161.00 and gave the stock an “outperform” rating in a report on Tuesday, December 12th. Finally, Wells Fargo reiterated an “outperform” rating and set a $160.00 price objective (up from $155.00) on shares of Johnson & Johnson in a report on Friday, January 12th. Four analysts have rated the stock with a sell rating, nine have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. Johnson & Johnson has a consensus rating of “Hold” and a consensus price target of $146.26.
In other news, VP Paulus Stoffels sold 155,342 shares of Johnson & Johnson stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $129.86, for a total value of $20,172,712.12. Following the transaction, the vice president now directly owns 357,906 shares in the company, valued at $46,477,673.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.19% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/03/17/johnson-johnson-jnj-stake-increased-by-chicago-partners-investment-group-llc.html.
Johnson & Johnson Profile
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.